Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic Foundation has published research in the area of finding better markers to identify Thyroid Cancer. Learn more in this interview with Dr. Mark Nolan Hill.
Thyroid Cancer Detection
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Overview
Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic Foundation has published research in the area of finding better markers to identify Thyroid Cancer. Learn more in this interview with Dr. Mark Nolan Hill.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
mIDH Gliomas Explained: Characteristics and Management Strategies
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?